In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...
Two abstracts win the prestigious AHA 2024 Paul Dudley White International Scholar Award Allschwil, Switzerland - September 5, 2024Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan ...
The Endothelin B Receptor pipeline drugs market research report outlays comprehensive information on the Endothelin B Receptor targeted therapeutics, complete with analysis by indications, stage of ...
The key targets in the Alport Syndrome pipeline products market include Endothelin 1 Receptor (Endothelin A Receptor or EDNRA), Dystrophin (DMD), and Free Radical. Alport syndrome is a genetic ...